Advenchen Laboratories, Llc
Clinical trials sponsored by Advenchen Laboratories, Llc, explained in plain language.
-
New Two-Drug attack on advanced cancers begins human testing
Disease control Recruiting nowThis early-stage trial is testing a new oral drug, AL8326, combined with an existing immunotherapy (toripalimab) for people with advanced solid tumors that have come back or spread. The main goals are to find the safest and most effective dose of the new combination and to see if…
Phase: PHASE1, PHASE2 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New oral drug trial offers hope for rare, Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing an oral medication called anlotinib for people with advanced forms of soft tissue sarcoma that have spread or cannot be removed by surgery. The main goal is to see if the drug can shrink tumors or slow their growth compared to standard chemotherapy. The tria…
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC